Pediatric Frontal and Nasal Bispectral Index

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2024

Conditions
BIS
Interventions
DEVICE

Bispectral index (BIS)

"* All patient will receive standard monitoring (EKG, Blood pressure, pulse oximetry), and BIS transducer placement at standard frontal area before anesthesia.~* Sedative medication can be given as appropriate.~* Anesthesia induction by inhalation induction with sevoflurane (if intravenous line not presented) or intravenous induction with thiopental 5-6 mg/kg IV~* Other medication including fentanyl 1 mcg/kg IV and cisatracurium 0.1-0.2 mg/kg IV will be given and the patient will be intubated.~* The second BIS will be installed on the bridge of the nose and temporal on the same side as frontal BIS.~* The patient will be maintained with sevoflurane and other anesthetic drugs as appropriate, adjusted per frontal BIS (40-60).~* The frontal BIS and the nasal BIS will be measured until the endotracheal tube is being removed. If the patient has moved until it was impossible to measure the BIS or has any necessity to cancel the BIS measurement. The BIS measurement can be stopped."

Trial Locations (1)

10700

Siriraj Hospital, Bangkok Noi

All Listed Sponsors
collaborator

Siriraj Hospital

OTHER

lead

Mahidol University

OTHER

NCT06255236 - Pediatric Frontal and Nasal Bispectral Index | Biotech Hunter | Biotech Hunter